DMK Pharmaceuticals Performance
| DMKPQDelisted Stock | 0.0001 0.00 0.00% |
DMK Pharmaceuticals holds a performance score of 15 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 25.86, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, DMK Pharmaceuticals will likely underperform. Use DMK Pharmaceuticals standard deviation and skewness , to analyze future returns on DMK Pharmaceuticals.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in DMK Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, DMK Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point. ...more
DMK |
DMK Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 0.00 in DMK Pharmaceuticals on October 4, 2025 and sell it today you would earn a total of 0.01 from holding DMK Pharmaceuticals or generate 9.223372036854776E16% return on investment over 90 days. DMK Pharmaceuticals is currently producing 37.037% returns and takes up 192.4501% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than DMK, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
DMK Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DMK Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as DMK Pharmaceuticals, and traders can use it to determine the average amount a DMK Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1925
| Best Portfolio | Best Equity | DMKPQ | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average DMK Pharmaceuticals is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DMK Pharmaceuticals by adding it to a well-diversified portfolio.
Things to note about DMK Pharmaceuticals performance evaluation
Checking the ongoing alerts about DMK Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for DMK Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DMK Pharmaceuticals is not yet fully synchronised with the market data | |
| DMK Pharmaceuticals is way too risky over 90 days horizon | |
| DMK Pharmaceuticals has some characteristics of a very speculative penny stock | |
| DMK Pharmaceuticals appears to be risky and price may revert if volatility continues |
- Analyzing DMK Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DMK Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining DMK Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DMK Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of DMK Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DMK Pharmaceuticals' pink sheet. These opinions can provide insight into DMK Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in DMK Pink Sheet
If you are still planning to invest in DMK Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DMK Pharmaceuticals' history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |